Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Valens submits site evidence package to Health Canada for manufacturing facility in GTA

Stockhouse Editorial
2 Comments| February 25, 2021

{{labelSign}}  Favorites
{{errorMessage}}

Click to enlargeKelowna BC-based cannabis extraction company The Valens Company Inc. (TSX.VLNS) – a leading manufacturer of cannabis products – has announced it has submitted a site evidence package to Health Canada under its existing micro-processing licence application for the Company's third facility in Canada, located in the Greater Toronto Area.

The GTA facility is now in the final stages of construction and will provide an additional 30,000 square feet of capacity, focused on the formulation, co-packing, and manufacturing of cannabis-infused beverages and other customized 2.0 and 3.0 products using SōRSE by Valens emulsion technology.

Full story here.


New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today